Scpharmaceuticals Inc (SCPH) - News Archive

Showing 3 of 3 results.

scPharmaceuticals Secures $125 Million in Non-Dilutive Financing, Empowering its Path to Innovation and Patient-Centric Care,

scPharmaceuticals Secures $75 Million in Non-Dilutive Financing to Support Continued GrowthIn a recent press release, scPharmaceuticals, a leading pharmaceutical company specializing in innovative drug delivery solution...

Aug 12, 2024 • Major Pharmaceutical Preparations Industry Financing Agreement

scPharmaceuticals Reports Successful Topline Results for SCP-111 Autoinjector, Meeting Key Pharmacokinetic and P...

scPharmaceuticals Announces Positive Topline Study Results for SCP-111 (Furosemide 80 mg/1 mL) AutoinjectorIn a significant advancement in patient care and pharmaceutical technology, scPharmaceuticals, a biopharmaceutic...

Aug 12, 2024 • Major Pharmaceutical Preparations Industry Clinical Study

Advancing Patient-Centric Care: scPharmaceuticals Enrolls First Participant in Pivotal Study of FUROSCIX Auto-Injector, Evolving Furosemide Delivery.

FUROSCIX Auto-injector being developed as a complement to the FUROSCIX On-body Infusor.In a significant development, leading pharmaceutical company scPharmaceuticals has recently announced the enrollment of its first pa...

Apr 24, 2024 • Major Pharmaceutical Preparations Industry Clinical Study